Everolimus in Treating Patients With Stage IV Melanoma
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as everolimus, work in different ways to stop the
growth of tumor cells, either by killing the cells or by stopping them from dividing.
Everolimus may also stop the growth of melanoma by blocking blood flow to the tumor.
PURPOSE: This phase II trial is studying how well everolimus works in treating patients with
stage IV melanoma.